DAMOCLES Dx has recently launched its pre-seed funding round to strengthen its research and development capabilities and support the commercialization of its innovative products.
This initiative is part of DAMOCLES Dx’s commitment to strengthening its scientific and technological work in the field of medical diagnostics, in a context marked by increasing challenges related to the reliability and speed of diagnostic tools.
The funds raised will support the continuation of research activities, the further development of technology validation phases, and the strengthening of the team around the project. This step also aims to lay the foundations necessary for the long-term development of the company’s solutions.
Through this funding round, DAMOCLES Dx reaffirms its commitment to developing diagnostic technologies that are useful, robust, and adapted to real-world needs, while meeting the specific requirements of the healthcare sector.
